{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:41:01Z","timestamp":1780522861154,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,20]]},"DOI":"10.7759\/cureus.69798","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:06:22Z","timestamp":1726844782000},"source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Anxiolytic Activity of Angiotensin Receptor Blockers Using Actophotometer Test in Wistar Rats"],"prefix":"10.7759","author":[{"given":"Chavda","family":"Akshayraj Vanrajbhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana M","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedant S","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartiki P","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leesha L","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30475-4","article-title":"The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990-2017","volume":"7","year":"2020","unstructured":"The burden of mental disorders across the states of India. the Global Burden of Disease Study 1990-2017. Lancet Psychiatry. 2020, 7:148-61. 10.1016\/S2215-0366(19)30475-4","journal-title":"Lancet Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin DS","year":"2014","unstructured":"Baldwin DS, Anderson IM, Nutt DJ, et al.. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014, 28:403-39. 10.1177\/0269881114525674","journal-title":"J Psychopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-012-1102-2","article-title":"The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases","volume":"465","author":"Wright JW","year":"2013","unstructured":"Wright JW, Harding JW. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch. 2013, 465:133-51. 10.1007\/s00424-012-1102-2","journal-title":"Pflugers Arch"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ph14020166","article-title":"Losartan improves memory, neurogenesis and cell motility in transgenic Alzheimer's mice","volume":"14","author":"Drews HJ","year":"2021","unstructured":"Drews HJ, Klein R, Lourhmati A, et al.. Losartan improves memory, neurogenesis and cell motility in transgenic Alzheimer's mice. Pharmaceuticals (Basel). 2021, 14:10.3390\/ph14020166","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2478\/s11536-011-0010-8","article-title":"Effects of angiotensin II receptor antagonists on anxiety and some oxidative stress markers in rat","volume":"6","author":"Ciobica A","year":"2011","unstructured":"Ciobica A, Bild V, Hritcu L, Padurariu M, Bild W. Effects of angiotensin II receptor antagonists on anxiety and some oxidative stress markers in rat. Open Med. 2011, 6:331-40. 10.2478\/s11536-011-0010-8","journal-title":"Open Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.173063","article-title":"Targeting the renin angiotensin system for the treatment of anxiety and depression","volume":"199","author":"Chrissobolis S","year":"2020","unstructured":"Chrissobolis S, Luu AN, Waldschmidt RA, Yoakum ME, D'Souza MS. Targeting the renin angiotensin system for the treatment of anxiety and depression. Pharmacol Biochem Behav. 2020, 199:10.1016\/j.pbb.2020.173063","journal-title":"Pharmacol Biochem Behav"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1053136","article-title":"Renin-angiotensin system: the underlying mechanisms and promising therapeutical target for depression and anxiety","volume":"13","author":"Gong S","year":"2022","unstructured":"Gong S, Deng F. Renin-angiotensin system: the underlying mechanisms and promising therapeutical target for depression and anxiety. Front Immunol. 2022, 13:10.3389\/fimmu.2022.1053136","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00655-9","article-title":"Expanding telmisartan\u2019s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders","volume":"10","author":"Ahire YS","year":"2024","unstructured":"Ahire YS, Bairagi VA, Somavanshi DB, Jadhav SR, Jadhav SB, Jagtap SD. Expanding telmisartan\u2019s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders. Futur J Pharm Sci. 2024, 10:10.1186\/s43094-024-00655-9","journal-title":"Futur J Pharm Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2009.04.012","article-title":"In vivo angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland","volume":"23","author":"S\u00e1nchez-Lemus E","year":"2009","unstructured":"S\u00e1nchez-Lemus E, Benicky J, Pavel J, Saavedra JM. In vivo angiotensin II AT1 receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland. Brain Behav Immun. 2009, 23:945-57. 10.1016\/j.bbi.2009.04.012","journal-title":"Brain Behav Immun"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2011.03.003","article-title":"Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies","volume":"64","author":"Lynch JJ 3rd","year":"2011","unstructured":"Lynch JJ 3rd, Castagn\u00e9 V, Moser PC, Mittelstadt SW. Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies. J Pharmacol Toxicol Methods. 2011, 64:74-80. 10.1016\/j.vascn.2011.03.003","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-7634(96)00058-9","article-title":"Anxiety, defence and the elevated plus-maze","volume":"21","author":"Rodgers RJ","year":"1997","unstructured":"Rodgers RJ, Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev. 1997, 21:801-10. 10.1016\/s0149-7634(96)00058-9","journal-title":"Neurosci Biobehav Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20183023","article-title":"A study on anxiolytic activity and locomotor behavior of Curcuma amada rhizomes using Wistar albino rats","volume":"7","author":"Raj PV","year":"2018","unstructured":"Raj PV, N MR, Nayak RP, Rao SN. A study on anxiolytic activity and locomotor behavior of Curcuma amada rhizomes using Wistar albino rats. Int J Basic Clin Pharmacol. 2018, 7:1557-60. 10.18203\/2319-2003.ijbcp20183023","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1953.tb00749.x","article-title":"The measurement of the influence of drugs on voluntary activity in mice","volume":"8","author":"DE PB","year":"1953","unstructured":"DE PB. The measurement of the influence of drugs on voluntary activity in mice. Br J Pharmacol Chemother. 1953, 8:46-8. 10.1111\/j.1476-5381.1953.tb00749.x","journal-title":"Br J Pharmacol Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5214\/ans.0972.7531.1118204","article-title":"Study of CNS depressant and behavioral activity of an ethanol extract of Achyranthes Aspera (Chirchita) in mouse model","volume":"18","author":"Bhosale U","year":"2011","unstructured":"Bhosale U, Yegnanarayan R, Prachi P, Zambare M, Somani RS. Study of CNS depressant and behavioral activity of an ethanol extract of Achyranthes Aspera (Chirchita) in mouse model. Ann Neurosci. 2011, 18:44-7. 10.5214\/ans.0972.7531.1118204","journal-title":"Ann Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(03)00036-2","article-title":"Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats","volume":"78","author":"Srinivasan J","year":"2003","unstructured":"Srinivasan J, Suresh B, Ramanathan M. Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats. Physiol Behav. 2003, 78:585-91. 10.1016\/S0031-9384(03)00036-2","journal-title":"Physiol Behav"},{"key":"ref16","article-title":"Evaluation of antianxiety activity of angiotensin receptor blockers in albino mice","volume":"3","author":"Swetha ES","year":"2014","unstructured":"Swetha ES, Aithal S, Rubina A. Evaluation of antianxiety activity of angiotensin receptor blockers in albino mice. Sch Acad J Pharm. 2014, 3:350-3.","journal-title":"Sch Acad J Pharm"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1042\/CS20120078","article-title":"Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders","volume":"123","author":"Saavedra JM","year":"2012","unstructured":"Saavedra JM. Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond). 2012, 123:567-90. 10.1042\/CS20120078","journal-title":"Clin Sci (Lond)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol S","year":"2015","unstructured":"Villapol S, Saavedra JM. Neuroprotective effects of angiotensin receptor blockers. Am J Hypertens. 2015, 28:289-99. 10.1093\/ajh\/hpu197","journal-title":"Am J Hypertens"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00074","article-title":"The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders","volume":"4","author":"Olivier JD","year":"2013","unstructured":"Olivier JD, Vinkers CH, Olivier B. The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Front Pharmacol. 2013, 4:10.3389\/fphar.2013.00074","journal-title":"Front Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.09.013","article-title":"Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells","volume":"198","author":"Cianchetti S","year":"2008","unstructured":"Cianchetti S, Del Fiorentino A, Colognato R, Di Stefano R, Franzoni F, Pedrinelli R. Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis. 2008, 198:22-8. 10.1016\/j.atherosclerosis.2007.09.013","journal-title":"Atherosclerosis"},{"key":"ref21","article-title":"Evaluation of in vitro antioxidant activity of Oxalis latifolia Kunth and its role in the treatment of neurodegenerative diseases","volume":"5","author":"Subramanian A","year":"2018","unstructured":"Subramanian A. Evaluation of in vitro antioxidant activity of Oxalis latifolia Kunth and its role in the treatment of neurodegenerative diseases. Eur J Pharm Med Res. 2018, 5:545-51.","journal-title":"Eur J Pharm Med Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2014.151","article-title":"Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant \u03b2-blockers in the cardiovascular systems of spontaneously hypertensive rats","volume":"38","author":"Yoo SM","year":"2015","unstructured":"Yoo SM, Choi SH, Jung MD, Lim SC, Baek SH. Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant \u03b2-blockers in the cardiovascular systems of spontaneously hypertensive rats. Hypertens Res. 2015, 38:106-15. 10.1038\/hr.2014.151","journal-title":"Hypertens Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/282540-evaluation-of-anxiolytic-activity-of-angiotensin-receptor-blockers-using-actophotometer-test-in-wistar-rats","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:06:24Z","timestamp":1726844784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/282540-evaluation-of-anxiolytic-activity-of-angiotensin-receptor-blockers-using-actophotometer-test-in-wistar-rats"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.69798","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,20]]}}}